174
Participants
Start Date
November 22, 2024
Primary Completion Date
March 31, 2027
Study Completion Date
April 30, 2027
Lumateperone high dose
Lumateperone administered orally once daily
Lumateperone low dose
Lumateperone administered orally once daily
Placebo
Matching Placebo administered orally once daily
RECRUITING
Clinical Site, Petersburg
RECRUITING
Clinical Site, Savannah
RECRUITING
Clinical Site, Jacksonville
RECRUITING
Clinical Site, Gainesville
RECRUITING
Clinical Site, Miami Lakes
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Miami Springs
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, West Palm Beach
RECRUITING
Clinical Site, Dothan
RECRUITING
Clinical Site, Nashville
RECRUITING
Clinical Site, Garfield
RECRUITING
Clinical Site, Westlake
NOT_YET_RECRUITING
Clinical Site, Cincinnati
NOT_YET_RECRUITING
Clinical Site, Arlington Heights
RECRUITING
Clinical Site, Springfield
RECRUITING
Clinical Site, Saint Charles
NOT_YET_RECRUITING
Clinical Site, Frisco
RECRUITING
Clinical Site, Plano
NOT_YET_RECRUITING
Clinical Site, Dallas
RECRUITING
Clinical Site, Houston
RECRUITING
Clinical Site, Richmond
RECRUITING
Clinical Site, Colorado Springs
RECRUITING
Clinical Site, Phoenix
NOT_YET_RECRUITING
Clinical Site, Peoria
RECRUITING
Clinical Site, Las Vegas
NOT_YET_RECRUITING
Clinical Site, Buena Park
RECRUITING
Clinical Site, Upland
RECRUITING
Clinical Site, West Covina
RECRUITING
Clinical Site, Oceanside
RECRUITING
Clinical Site, Redlands
RECRUITING
Clinical Site, Anaheim
NOT_YET_RECRUITING
Clinical Site, Corona
RECRUITING
Clinical Site, Bellevue
NOT_YET_RECRUITING
Clinical Site, Boston
Lead Sponsor
Intra-Cellular Therapies, Inc.
INDUSTRY